← All stocks

enGene Therapeutics Inc.

ENGN Net buying
CIK 0001980845 #4240 in the set updated 21 Sep 2026
Bought (120 mo)
$8.07M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$787.98K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$787.98K
3 of 3 sales
Net
+$7.28M
+$7.28M against sales at will

By person

8 insiders · 20 transactions
0.1×

Ronald H.W. Cooper holds only 0.1 times base salary in stock. $89.00K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ronald H.W. Cooper last reported holding, valued at $8.90, the price Common Shares was last bought or sold at on the open market here, on 30 Oct 2024.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Forbion Growth Opportunities Fund I Cooperatief U.A. entity
10% owner
$8.01M (14)
+$8.01M
3,032,430
$26.99M
+51.6%
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
10% owner
$787.98K (3)
−$787.98K
3,036,153
$27.02M
−1.7%
Cooper Ronald Harold Wilfred
CEO & President
$57.00K (1)
+$57.00K
10,000
$89.00K
Forbion Growth Sponsor FEAC I B.V.
10% owner
3,765,932
$33.52M
+174.2%
BRUNK GERALD A
Director
238,851
$2.13M
Lumira Capital Investment Management Inc. entity
10% owner
238,851
$2.13M
CHEUNG ANTHONY TZEYEW
Chief Scientific Officer
102,873
$915.57K
Glickman Richard M
Director
24,675
$219.61K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
22 Apr 2024
10% owner
Sell
47,854
$15.00
$717.81K
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
19 Apr 2024
10% owner
Sell
100
$15.00
$1.50K
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
18 Apr 2024
10% owner
Sell
4,575
$15.01
$68.67K

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 7,169,283
History held since 2 Nov 2023